A new cholesterol treatment has shown promising early results, suggesting that a single administration could substantially lower harmful cholesterol levels and maintain the effect for an extended period. The initial data have attracted attention from the medical community, with researchers noting the potential for a more convenient and effective approach to managing high cholesterol. However, experts caution that the therapy also carries a significant drawback that could limit its widespread use. While the exact nature of the limitation has not yet been fully disclosed, it underscores the need for further research and clinical trials to fully assess the treatment’s safety and long‑term efficacy.
Article source: Verdens Gang | Image credit: Verdens Gang